Fresenius SE & Co. (FSNUY) to Release Quarterly Earnings on Wednesday

Posted by Trevor Kearing on Jul 29th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) is projected to release its resultson Wednesday, August 5th. Analysts expect the company to post earnings of $0.25 per share and revenue of $6.6540 billion for the quarter.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%.The firm had revenue of $6.75 billion during the quarter, compared to analysts’ expectations of $6.79 billion. On average, analysts expect Fresenius SE & Co. to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fresenius SE & Co. Price Performance

FSNUY opened at $12.71 on Wednesday. Fresenius SE & Co. has a 12-month low of $10.33 and a 12-month high of $33.93. The company has a current ratio of 1.27, a quick ratio of 0.98 and a debt-to-equity ratio of 0.41. The business’s fifty day simple moving average is $11.55 and its 200-day simple moving average is $12.84. The company has a market capitalization of $28.63 billion, a price-to-earnings ratio of 16.95 and a beta of 0.63.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Check Out Our Latest Stock Report on Fresenius SE & Co.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.